CLINUVEL PHARMACEUTICALS LIMITED

0.22%

$9.10

Market Cap $459.9M

Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on... Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.More

ASX:AFP

US growth, Injectable Iron Pipeline: How AFT Pharmaceuticals (ASX: AFP) is Driving Toward $300m by FY27

Latest Threads

Tag

Subject

CUV

DISC FDA Failure & CashBurn vs CLINUVEL CASH Printing Machine

2 3 4

18/04/26

186

51K

18/04/26

Last post Melon felon!

186

51K

CUV

Self-Bronzing Presentation April 2026 - WIRED Health Conference

17/04/26

9.6K

17/04/26

Last post rpape1

9.6K

CUV

Ann: Notification of cessation of securities - CUV

17/04/26

273

17/04/26

Last post

ASX News

273

CUV

Ever heard a MD make such a bullish statement?

14/04/26

6.1K

14/04/26

Last post rpape1

6.1K

CUV

Ann: Change in substantial holding

14/04/26

1.1K

14/04/26

Last post cuv101

1.1K

CUV

Ann: Application for quotation of securities - CUV

13/04/26

684

13/04/26

Last post rpape1

684

CUV

Ann: Section 708A Cleansing Statement

13/04/26

281

13/04/26

Last post

ASX News

281

CUV

Ann: CLINUVEL reports highlights from AAD 2026

12/04/26

8.5K

12/04/26

Last post htae39

8.5K

See All Discussions

Timeline

Notification of cessation of securities - CUV
17 Apr 09:04	Share

Section 708A Cleansing Statement
13 Apr 08:50	Share

Application for quotation of securities - CUV
13 Apr 08:49	Share

Change in substantial holding
13 Apr 08:18	Share

CLINUVEL reports highlights from AAD 2026
02 Apr 12:15	Share

CLINUVEL's global programs showcased at AAD
27 Mar 08:35	Share

Chair Letter to Shareholders
20 Mar 08:30	Share

CLINUVEL Investor Webinar Half Year Results December 2025
05 Mar 09:48	Share

Half Year Results Presentation
26 Feb 09:58	Share

CLINUVEL Record Revenues, Advances Strategic Expansion
26 Feb 09:55	Share

Appendix 4D and Half Year Report
26 Feb 09:54	Share

CLINUVEL Investor Webinar
19 Feb 09:04	Share

Clinical & Financial Update
02 Feb 08:30	Share

Managing Director Letter to Shareholders
15 Jan 09:11	Share

CLINUVEL - injectable peptide platform in preclinical study
12 Jan 08:42	Share

SCENESSE efficacy in vitiligo - new cases presented at RDTC
08 Jan 09:44	Share

Notification of cessation of securities - CUV
02 Jan 09:22	Share

CLINUVEL progresses Level II ADR upgrade, Nasdaq uplist
19 Dec 08:34	Share

CLINUVEL expands Singapore RD&I Centre
08 Dec 08:33	Share

CLINUVEL advances NEURACTHEL Instant, EU filing mid-2026
02 Dec 10:38	Share

Stifel Healthcare Conference presentation
14 Nov 08:25	Share

Change in substantial holding
12 Nov 08:30	Share

Update on ADR upgrade, Nasdaq uplisting
03 Nov 09:51	Share

Results of Meeting
17 Oct 13:00	Share

Managing Director Address
17 Oct 12:54	Share

Chair address
17 Oct 10:03	Share

Health Canada requests additional time for SCENESSE review
16 Oct 12:43	Share

Section 708A Cleansing Statement
03 Oct 08:55	Share

Notification of cessation of securities - CUV
03 Oct 08:53	Share

Application for quotation of securities - CUV
03 Oct 08:51	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last $9.10		Change -0.020(0.22%)		Mkt cap ! $459.9M

Open	High	Low	Volume
$9.20	$9.29	$9.02	121.1K

Buyers (Bids)

Vol.	Price($)
1500	$9.10

Sellers (Offers)

Price($)	Vol.
$9.28	1000

Last trade - 16.25pm 20/04/2026 (20 minute delay)

CUV (ASX) Chart

CLINUVEL PHARMACEUTICALS LIMITED

Latest Threads

DBO - Further High-Grade Critical Minerals Results Extend Target Zones at Star Range, Utah

Timeline

Featured News

Latest Articles

Clinuvel shares dip, even as CEO comes back from temp leave

After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...

Clinuvel stroke drug shows 'positive' results – but some adverse effects left unclear

Clinuvel shares jumped on Tuesday on higher volumes as the company reported a clinical trial win with its stroke drug, 'PRENUMBRA.'

British study shows Clinuvel drug effective on DNA of UV-damaged skin

Clinuvel Pharmaceuticals Ltd has reported final results of its study of the efficacy of afamelanotide to repair the DNA of damaged skin.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News